Bacteriophage Therapy Updates
13 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which drug became a valuable agent for the treatment of severe infections due to carbapenemase-producing Enterobacteriaceae since 2017?

  • Imipenem-Relebactam
  • Meropenem-Cilastatin
  • Meropenem-Avibactam (correct)
  • Ceftazidime-Avibactam
  • What is the primary mechanism by which β-lactam antibiotics exert their antibacterial effect?

  • Inhibition of bacterial DNA synthesis
  • Inhibition of bacterial protein synthesis
  • Inhibition of bacterial cell wall synthesis (correct)
  • Disruption of the bacterial cell membrane
  • What is the main action of beta-lactamases in bacterial resistance to β-lactam antibiotics?

  • Blocking β-lactam antibiotic entry into the cell
  • Hydrolyzing the β-lactam ring (correct)
  • Effluxing β-lactam antibiotics out of the cell
  • Plasmid-mediated antibiotic deactivation
  • Which strategy is NOT mentioned as a way to mitigate the spread of resistance to β-lactam antibiotics?

    <p>Increasing dosages of existing antibiotics</p> Signup and view all the answers

    What are β-lactam antibiotics most prevalently classified as?

    <p>Antibacterial agents</p> Signup and view all the answers

    What is the primary advantage of the BLBLIs in combination with BLs?

    <p>They restore the efficacy of BLs against resistant bacteria.</p> Signup and view all the answers

    What critical function does AIDsense serve in clinical settings?

    <p>It allows rapid confirmation of beta-lactamase resistance.</p> Signup and view all the answers

    How does Avibactam contribute to the effectiveness of β-lactams?

    <p>It restores the activity of β-lactams against resistant bacteria.</p> Signup and view all the answers

    Which designation is commonly granted to new associations of BLs: BLBLIs under research?

    <p>Qualified Infectious Disease Product (QIDP)</p> Signup and view all the answers

    What was a significant problem with the previous AID phenotypic method that AIDsense aims to improve?

    <p>Low accuracy in detecting beta-lactamase</p> Signup and view all the answers

    Why is the re-investigation of the oldest and best-known class of drugs considered beneficial?

    <p>They may help present and future societies by restoring usage.</p> Signup and view all the answers

    What is the goal of using β-lactam antibiotics in combination with novel beta-lactamase inhibitors?

    <p>To restore the efficacy of underused antibiotics</p> Signup and view all the answers

    What urgent need is highlighted regarding antibacterial agents in the context?

    <p>The creation of agents to combat drug-resistant infections</p> Signup and view all the answers

    Study Notes

    The Revival of β-Lactam Antibiotics

    • β-Lactam antibiotics are the most widely used and successful antibacterial agents, but their effectiveness is challenged by resistance mediated by beta-lactamases.
    • The combination of a β-lactam with a β-lactamase inhibitor (BLBLI) can restore the efficacy of otherwise ineffective antibiotics.

    Development of New Antibacterial Agents

    • Many associations of BLs (BLBLIs) are under research and development, with some granted the Qualified Infectious Disease Product (QIDP) designation.
    • Pharmaceutical companies are investing in research and development of new antibacterials, including renewed β-lactam antibiotics with activity against problematic and multidrug-resistant Gram-negative pathogens.

    AIDsense: A Novel Detection Method

    • AIDsense is a novel method for β-lactamase detection with direct potential clinical applications as a diagnostic tool.
    • It allows clinics/laboratories to rapidly confirm beta-lactamase resistance and identify the responsible gene, which is critical for epidemiological purposes.

    β-Lactam Antibiotics and β-Lactamase Inhibitors

    • β-Lactam antibiotics inhibit bacterial cell wall synthesis (peptidoglycan), leading to cell lysis.
    • β-Lactamase inhibitors, such as Avibactam, can restore the activity of different classes of β-lactams, including Cephalosporin, against multi-drug resistant bacterial infections.
    • Meropenem-Avibactam has been a valuable agent for treating severe infections due to carbapenemase-producing Enterobacteriaceae since 2017.

    Mitigating Resistance

    • Strategies to mitigate the spread of resistance include optimizing current β-lactamase inhibitors and developing novel “renewed” β-lactam antibiotics.
    • The development of new antibacterial agents is urgently needed to combat drug-resistant infections.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Learn about the latest developments in bacteriophage therapy, including the research and development of new antibacterials and the re-investigation of old antibiotics.

    More Like This

    Bacteriophage Quiz
    277 questions

    Bacteriophage Quiz

    RewardingOlive avatar
    RewardingOlive
    Bacteriophage Genetics and Applications Quiz
    44 questions
    Bacteriophage Isolation and Life Cycle
    12 questions
    Use Quizgecko on...
    Browser
    Browser